The PET/CT Scan service plays a crucial role in the diagnosis and staging of cancer, as well as investigating other diseases. PET/CT Scan combines Positron Emission Tomography (PET) and Computed Tomography (CT) technologies to provide detailed images of the body's organs and tissues.

The hospital's in-house cyclotron enables the production of PET radiopharmaceuticals, including F-18 FDG, F-18 NaF, F-18 FD0PA, and C-11 PiB. These radiopharmaceuticals are used in the PET/CT Scan procedure to detect and visualize metabolic activity and abnormalities within the body.

The PET/CT Scan service is led by expert oncology radiologists who specialize in oncology imaging. They utilize CT scans and ultrasound in addition to PET imaging to provide comprehensive and accurate diagnoses.

Our hospital offers PET/CT Scan with floe technology, which is the world's first PET/CT system to eliminate the need for stop-and-go imaging. With continuous motion of the patient table during scanning, the procedure is faster and more convenient for patients, providing a smooth and comfortable experience.

Currently, the most commonly used radiopharmaceutical in PET/CT scans is F-18 FDG, which is effective in diagnosing various types of cancer. However, other radiopharmaceuticals such as F-18 FD0PA are used for specific cancers and brain disorders like Parkinson's and other movement disorders. C-11 PiB (Pittsburgh Compound) is applicable in the diagnosis of Alzheimer's disease.

The PET/CT Scan service utilizes advanced technology and specialized radiopharmaceuticals to provide accurate and comprehensive imaging for diagnosis and staging of cancer, as well as the evaluation of other diseases. The combination of PET and CT imaging allows for a more detailed understanding of the body's condition, aiding in effective treatment planning and monitoring of patients' progress.